← Back to Search

Pecs II Block vs Surgical Infiltration for Postoperative Pain in Tendinopathy

Phase 4
Waitlist Available
Led By Arthur Hertling, MD
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24-48 hours
Awards & highlights

Study Summary

This trial looks at two ways to control pain after surgery, and whether one is better than the other at reducing pain and the need for pain medication.

Eligible Conditions
  • Tendonitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24-48 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24-48 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Opioid utilization for the first 24 hours after surgery, including during surgery, calculated as oxycodone equivalent
Secondary outcome measures
Incidence of patient reaction to surgical subpectoral incision
Patient reported Visual Analog Scale (VAS) score at postoperative day 1 (POD 1)
Patient reported Visual Analog Scale (VAS) score at postoperative day 3 (POD 3)
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Pecs II blockExperimental Treatment1 Intervention
80 patients scheduled for open biceps tenodesis
Group II: Surgical infiltrationActive Control1 Intervention
80 patients scheduled for open biceps tenodesis
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Pecs II block
2014
Completed Phase 4
~240

Find a Location

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,367 Previous Clinical Trials
839,601 Total Patients Enrolled
Arthur Hertling, MDPrincipal InvestigatorNYU Langone Health
3 Previous Clinical Trials
88 Total Patients Enrolled

Media Library

Pecs II block Clinical Trial Eligibility Overview. Trial Name: NCT04867369 — Phase 4
Tendonitis Research Study Groups: Pecs II block, Surgical infiltration
Tendonitis Clinical Trial 2023: Pecs II block Highlights & Side Effects. Trial Name: NCT04867369 — Phase 4
Pecs II block 2023 Treatment Timeline for Medical Study. Trial Name: NCT04867369 — Phase 4

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the participant enrollment size of this investigation?

"Affirmative. The online resource clinicaltrials.gov indicates that this research project, first posted on July 14th 2021, is actively recruiting participants. 160 patients need to be identified from a single medical site."

Answered by AI

What qualifications are needed to participate in this research project?

"This clinical research is seeking 160 individuals with tendonitis, aged 18-75. To quality for the study, prospective participants must be within this age range and have already undergone shoulder arthroscopy with open subpectoral biceps tenodesis."

Answered by AI

Does this trial cater to participants younger than thirty years of age?

"This clinical trial has set a lower age limitation of 18 and an upper limit of 75 for patient enrollment, in compliance with the stated criteria."

Answered by AI

Are participants currently being recruited for this research project?

"Affirmative. Clinicaltrials.gov's records indicate that this trial is currently recruiting participants, having been first posted on July 14th 2021 and recently updated on June 14th 2022. The study aims to include 160 patients from a single site of research."

Answered by AI

What potential harms could result from a Pecs II block procedure?

"Our team has assigned Pecs II block a score of 3, as it is in its fourth phase and thus already approved for use."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Pecs II Block Versus Surgeon Infiltration for Open Subpectoral Biceps Tenodesis
2021. "Pecs II Block Versus Surgeon Infiltration for Open Subpectoral Biceps Tenodesis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04867369.
~43 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top